Loading candles…
Vineet Laboratories Ltd, incorporated in 2003 and headquartered in Hyderabad, India, operates in the pharmaceutical and life sciences industries. The company designs, develops, and manufactures active pharmaceutical ingredients (APIs), API intermediates, bulk drugs, and chemical intermediates. It specializes in managing complex and hazardous chemical processes. Vineet Laboratories serves both domestic and international markets and maintains significant manufacturing infrastructure to support a range of process chemistries. No publicly available information is listed regarding its founders, key management, subsidiaries, or stock exchange listings.
This page is a live market overview for VINEET LABORATORIES LTD (VINEETLAB) on the NSE. As a listed security, VINEET LABORATORIES LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for VINEETLAB before placing trades on tick2trade.
As of the latest feed, VINEETLAB last traded at ₹35.3 on NSE, up ₹0.49 (1.41%) from the previous close of ₹34.81. Today's session range is ₹34.25 – ₹35.89, against a 52-week band of ₹27.96 – ₹43.5. Traded volume today stands at 48.04K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for VINEETLAB in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether VINEETLAB is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for VINEET LABORATORIES LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in VINEETLAB. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated VINEETLAB option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 30 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 along with the limited review report. | 14 Feb 2026 |
| Fund Raising | To consider and approve the proposal of Fund Raising by way of issue of equity shares through Rights Issue. | 27 Nov 2025 |
| Results - Q2 & FY25 | To consider and approve the financial results for second quarter & the half year ended on September 30, 2025 along with the limited review report | 8 Nov 2025 |
| Unaudited Results - Q1-FY25 | Intimation of the date of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to consider and appro… | 22 Jul 2025 |
| Audited Results - Q4 & FY25 | To consider and approve the Audited Standalone Financial Results of the Company for the Fourth Quarter and the Financial Year ended on March 31, 2025. | 12 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.